Lack of ability of ciprofloxacin-rifampin prophylaxis to decrease infection-related morbidity in neutropenic patients given cytotoxic therapy and peripheral blood stem cell transplants
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.